🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate visual improvement in patients treated with Immune...
Status
Completed
Location
Universitatsklinikum Aachen, Augenklinik
Start Date
2004-01
Trial ID
NCT00220805
This study proposes the use of a reduced intensity chemotherapy/radiation t...
Status
Completed
Location
Columbia University Medical Center
Start Date
2002-09
Trial ID
NCT01019876
The trial will study 2 doses of Immune Globulin Intravenous (Human), 10% Ca...
Status
Completed
Location
Barrow Neurological Institute at St. Joseph's Hospital and Medical Center
Start Date
2002-12
Trial ID
NCT00220779
The main goal of this study is to show that people with certain immune prob...
Status
Recruiting
Location
Study Site 102
Start Date
2026-04-23
Trial ID
NCT07582432
Treatments Being Tested
The intent of this study is to demonstrate the efficacy and safety of Immun...
Status
Completed
Location
Yale University School of Medicine
Start Date
2004-04
Trial ID
NCT00220740
The purpose of this study is to test the safety and efficacy of Civacir® to...
Status
Completed
Location
University of Southern California / Keck Hospital
Start Date
2013-06
Trial ID
NCT01804829
Treatments Being Tested
This study will compare the blood level of Gamunex in patients. Patients wi...
Status
Completed
Location
University of California, Irvine
Start Date
2006-11
Trial ID
NCT00389324
Treatments Being Tested
The purpose of this open-label study is to evaluate the pharmacokinetics, s...
Status
Completed
Location
Childrens Hospital Los Angeles
Start Date
2011-11
Trial ID
NCT01465958
The LCH-IV is an international, multicenter, prospective clinical study for...
Status
Active Not Recruiting
Location
Children's of Alabama
Start Date
2016-11-02
Trial ID
NCT02205762
The objective of this study is to determine if the safety and tolerability ...
Status
Completed
Location
New York Presbyterian Hospital
Start Date
2003-07
Trial ID
NCT00220727
Treatments Being Tested